A prospective, randomized controlled trial comparing LNG-IUS (n=30) and TBA (n=28) was performed. Hysterectomy rates, hemoglobin level, bleeding pattern, well-being status and satisfaction rates were assessed. Comparisons between groups were performed by ¦Ö2 test and by unpaired and paired t tests.
After 5 years of follow-up, women treated with a TBA had higher rates of hysterectomy (24 % ) compared to the LNG-IUS group (3.7 % ) due to treatment failure (p=.039). Use of LNG-IUS resulted in higher mean hemoglobin (¡À SD) levels in comparison to the TBA group (14.1¡À0.3 vs 12.7¡À0.4 g/dL, p=.009). Menstrual blood loss was significantly higher in the TBA when compared to the LNG-IUS group (45.5 % vs 0.0 % p<.001). The psychological general well-being index scores were similar. Patient acceptability, perceived clinical improvement and overall satisfaction rates were significantly higher in women using LNG-IUS.
Five-year follow-up of HMB treatment with LNG-IUS was associated with higher efficacy and satisfaction ratings compared to TBA.